Free Trial
→ What Is the $7,882 Stimulus Payment 2024? (From Angel Publishing) (Ad)

LifeTech Capital Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at LifeTech Capital. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by LifeTech Capital.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
Export to Excel
CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
Sonoma Pharmaceuticals, Inc. stock logo
SNOA
Sonoma Pharmaceuticals
$3.00
+4.9%		11/9/2011Reiterated byLifeTech Capital-Strong-Buy -> Buy$4.75N/AView details for LifeTech Capital rating of Sonoma Pharmaceuticals (NASDAQ:SNOA) on 11/9/2011
Sonoma Pharmaceuticals, Inc. stock logo
SNOA
Sonoma Pharmaceuticals
$3.00
+4.9%		6/13/2011Reiterated byLifeTech Capital-Strong Buy -> BuyN/AView details for LifeTech Capital rating of Sonoma Pharmaceuticals (NASDAQ:SNOA) on 6/13/2011

MarketBeat Community Rating for LifeTech Capital

Community Ranking:  2.6 out of 5 (
2.6 of 5 stars)
Outperform Votes:  29,145 (Vote Outperform)
Underperform Votes:  25,915 (Vote Underperform)
Total Votes:  55,060
MarketBeat's community ratings are surveys of what our community members think about LifeTech Capital and other research firms. Vote "Outperform" if you believe LifeTech Capital's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LifeTech Capital's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.
Today's Ratings:
Top Rated Stocks:
More Ratings Tools: